What does DR. TIMMERMAN MARYSE do?

DR. TIMMERMAN MARYSE is a specialist medical practice in Kampenhout. Private Limited, started on 5 December 2001.

What is the address of DR. TIMMERMAN MARYSE?

The registered office of DR. TIMMERMAN MARYSE is located at Tiendeschuurstraat 56, 1910 Kampenhout.

Is DR. TIMMERMAN MARYSE still active?

Yes. According to the CBE (31 October 2026) DR. TIMMERMAN MARYSE is active, legal situation “Normale toestand”, started on 5 December 2001.

Is DR. TIMMERMAN MARYSE registered on Peppol?

Yes, DR. TIMMERMAN MARYSE is registered on the Peppol network with ID 0208:0476240405.

What is the enterprise number of DR. TIMMERMAN MARYSE?

The enterprise number of DR. TIMMERMAN MARYSE is BE0476240405.

When was DR. TIMMERMAN MARYSE founded?

DR. TIMMERMAN MARYSE was founded on 5 December 2001.

Who are the directors of DR. TIMMERMAN MARYSE?

According to the 2025 annual accounts, the directors of DR. TIMMERMAN MARYSE are: Maryse Timmerman.

Is DR. TIMMERMAN MARYSE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 December 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. TIMMERMAN MARYSE make in 2025?

DR. TIMMERMAN MARYSE recorded a loss after taxes of € 29,001 in financial year 2025.

What is the revenue of DR. TIMMERMAN MARYSE?

As a small company, DR. TIMMERMAN MARYSE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -31,998.

DR. TIMMERMAN MARYSE (Private Limited) - Kampenhout

Dossier DR. TIMMERMAN MARYSE, printed on 31 October 2026 from databakkes.be/en/0476240405/dr-timmerman-maryse. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. TIMMERMAN MARYSE from Kampenhout, company number BE0476240405, closed financial year 2025 with a result of € -29,001 after tax. For that financial year DR. TIMMERMAN MARYSE recorded a gross margin of € -31,998 and equity of € 253,919. Compared with financial year 2024, the result moved from € 19,492 to € -29,001. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Healthy

€ 253,919

▼ 10% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -29,001

▼ still € 19,492 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 171,315

▼ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 241,519.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,691

▼ 44% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 3,934 Gross margin 2022: € 3,934 First fiscal year in the series	€ 1,623 Gross margin 2023: € 1,623 ▼ 59% vs 2022 (€ 3,934) Unfavourable step	€ 33,462 Gross margin 2024: € 33,462 ▲ € 31,839 vs 2023 (€ 1,623) Favourable step	€ -31,998 Gross margin 2025: € -31,998 ▼ € 65,461 vs 2024 (€ 33,462) Unfavourable step	▼ € 65,461
Profit after taxes	€ 1,480 Profit after taxes 2022: € 1,480 First fiscal year in the series	€ 518 Profit after taxes 2023: € 518 ▼ 65% vs 2022 (€ 1,480) Unfavourable step	€ 19,492 Profit after taxes 2024: € 19,492 ▲ € 18,975 vs 2023 (€ 518) Favourable step	€ -29,001 Profit after taxes 2025: € -29,001 ▼ € 48,494 vs 2024 (€ 19,492) Unfavourable step	▼ € 48,494
Equity	€ 262,909 Equity 2022: € 262,909 First fiscal year in the series	€ 263,427 Equity 2023: € 263,427 Unchanged (€ 262,909) Favourable step	€ 282,920 Equity 2024: € 282,920 ▲ 7% vs 2023 (€ 263,427) Favourable step	€ 253,919 Equity 2025: € 253,919 ▼ 10% vs 2024 (€ 282,920) Unfavourable step	▼ 10%
Total debts	€ 7,366 Total debts 2022: € 7,366 First fiscal year in the series	€ 2,753 Total debts 2023: € 2,753 ▼ 63% vs 2022 (€ 7,366) Favourable step	€ 15,137 Total debts 2024: € 15,137 ▲ € 12,385 vs 2023 (€ 2,753) Unfavourable step	€ 1,691 Total debts 2025: € 1,691 ▼ 89% vs 2024 (€ 15,137) Favourable step	▼ 89%
Cash	€ 7,220 Cash 2022: € 7,220 First fiscal year in the series	€ 240,291 Cash 2023: € 240,291 ▲ € 233,070 vs 2022 (€ 7,220) Favourable step	€ 259,142 Cash 2024: € 259,142 ▲ 8% vs 2023 (€ 240,291) Favourable step	€ 171,315 Cash 2025: € 171,315 ▼ 34% vs 2024 (€ 259,142) Unfavourable step	▼ 34%
Land & buildings	€ 26 Land & buildings 2022: € 26 First fiscal year in the series	-	-	€ 0 Land & buildings 2025: € 0 First fiscal year in the series
Retained profit	€ 250,509 Retained profit 2022: € 250,509 First fiscal year in the series	€ 251,027 Retained profit 2023: € 251,027 Unchanged (€ 250,509) Favourable step	€ 270,520 Retained profit 2024: € 270,520 ▲ 8% vs 2023 (€ 251,027) Favourable step	€ 241,519 Retained profit 2025: € 241,519 ▼ 11% vs 2024 (€ 270,520) Unfavourable step	▼ 11%
Balance sheet total	€ 270,275 Balance sheet total 2022: € 270,275 First fiscal year in the series	€ 266,180 Balance sheet total 2023: € 266,180 ▼ 2% vs 2022 (€ 270,275) Unchanged	€ 298,057 Balance sheet total 2024: € 298,057 ▲ 12% vs 2023 (€ 266,180) Unchanged	€ 255,610 Balance sheet total 2025: € 255,610 ▼ 14% vs 2024 (€ 298,057) Unchanged	▼ 14%

Key figures of DR. TIMMERMAN MARYSE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. TIMMERMAN MARYSE?

What happened at DR. TIMMERMAN MARYSE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 30, 2026 New annual accounts for financial year 2025: loss of € 29,001 (▼ € 48,494 vs 2024). filed late Source: NBB ↗
Dec 5, 2001 Start of the company according to the CBE. KBO

In short

From € 1,480 profit in 2022 to € 29,001 loss in 2025.

Paid € 15,566 in corporate taxes since 2022.

Best year ever: 2024, with € 19,492 profit.

Original PDFs at the National Bank ↗

Management

Maryse Timmerman

DR. TIMMERMAN MARYSE

Behind DR. TIMMERMAN MARYSE is Maryse Timmerman.

Directors

According to the 2025 annual accounts

Maryse Timmerman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Tiendeschuurstraat 56

1910 Kampenhout

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0476.240.405
VAT number: BE 0476.240.405
Registered office: Tiendeschuurstraat 56, 1910 Kampenhout
Names & denominations: DR. TIMMERMAN MARYSE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 December 2001
Peppol: Active · Active since 12 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗